Latest from TCT 2017
A left atrial appendage closure device provided a similar level of stroke prevention to that of warfarin in patients with atrial fibrillation.
Percutaneous coronary intervention of the culprit lesion is associated with better 30-day outcomes than immediate multivessel PCI in patients with patients with multivessel CAD and acute MI.
Patients who received bioresorbable vascular scaffolds had higher rates of device thrombosis and target vessel MI compared with those who received everolimus-eluting stents.
Researchers analyzed 3-year outcomes in patients implanted with bioresorbable vascular scaffolds for the treatment of coronary lesions.
A substudy analyzed whether PCI outcomes using second generation drug eluting stents were comparable to CABG in patients with low or intermediated complexity left main coronary artery disease.
Sign Up for Free e-Newsletters
Check out what's trending
The Cardiology Advisor Articles
- Continuous Furosemide Infusion Superior to Bolus Furosemide in Heart Failure
- ACC/AHA Release 2017 Quality Measures for STEMI/NSTEMI Management
- Role of Coffee Consumption in Heart Failure, Stroke Outcomes
- Atrial Fibrillation Survival Better With Cardiac Surgery, Cox-Maze IV
- Borderline Pulmonary Hypertension Commonly Found During Right Heart Catheterization
- Heart Failure Related to Methamphetamine Use: Possible New Epidemic?
- Cardiac Surgery: Restrictive vs Liberal Threshold for Red-Cell Transfusion
- High-Sensitivity Cardiac Troponin I Threshold Identifies Patients at Low Risk for MI, Death
- Hospital Readmissions Reduction Program Decreases Heart Failure Readmissions
- Canakinumab May Lower Lung Cancer Incidence in Patients With Atherosclerosis